| Name | Title | Contact Details |
|---|---|---|
Peter Vladimirov |
Chief Technology Officer | Profile |
Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.
CP Medical is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our mission at Awair is to empower you with the knowledge, motivation, and confidence to be healthy and thrive in your environment.
LaBelle Strategic Resources is a Collegeville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dental USA Inc is a Mchenry, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.